过去一年中添加的文章,按日期排序
… hybrid hydrogels enable enhanced combination chemotherapy and roused anti-tumor immunity in the synergistic treatment of pancreatic ductal adenocarcinoma
H Zhou, W Wang, Z Cai, ZY Jia, YY Li, W He… - Journal of …, 2024 - Springer
22 天前 - … (PDAC) accounts for over 80% of all kinds of pancreatic cancer and it is known as
one … The tumor stroma ultimately results in desmoplasia and fibrotic responses creating a …
one … The tumor stroma ultimately results in desmoplasia and fibrotic responses creating a …
Fibroblast Activation Protein Inhibitor Theranostics: A Huge Opportunity with its Fair Share of Oncological Pitfalls
A Al-Ibraheem - World Journal of Nuclear Medicine, 2024 - thieme-connect.com
22 天前 - … , and drug resistance, making them a critical focus for cancer research and treatment
… desmoplastic reaction, such as breast, colon, hepatobiliary, gastrointestinal, pancreatic, …
… desmoplastic reaction, such as breast, colon, hepatobiliary, gastrointestinal, pancreatic, …
Enhancing Pancreatic Ductal Adenocarcinoma Immunotherapy Through the Inhibition of Focal Adhesion Kinase
A Wu - jmsgr.tamhsc.edu
30 天前 - … of drug resistance that has been elucidated is the development of a unique desmoplastic
stroma that grows around the PDAC tumor … and creates a tumor microenvironment with …
stroma that grows around the PDAC tumor … and creates a tumor microenvironment with …
Phase II trial of BXCL701 and pembrolizumab in patients with metastatic pancreatic ductal adenocarcinoma (EXPEL-PANC): Preliminary findings.
BA Weinberg, A Lekan, A Fitzgerald, Z Malchiodi… - 2024 - ascopubs.org
37 天前 - … , due to a tumor microenvironment (TME) consisting of a desmoplastic stroma and
poor T cell … with mPDAC refractory to chemotherapy. Clinical trial information: NCT05558982. …
poor T cell … with mPDAC refractory to chemotherapy. Clinical trial information: NCT05558982. …
[HTML][HTML] Pancreatic infiltrative malignancy masquerading as autoimmune pancreatitis: Case report, review of radiological criteria, and literature
H Vardevanyan, M Hager, F Renneberg… - Radiology Case …, 2024 - Elsevier
39 天前 - … diagnosis was much delayed and the patient started receiving chemotherapy, but
… Desmoplastic reaction adjacent to pancreatic cancer can be quite severe which can be …
… Desmoplastic reaction adjacent to pancreatic cancer can be quite severe which can be …
Novel in-vitro and in-vivo strategies to study pancreatic ductal adenocarcinoma progression and chemoresistance
KK Chougoni - Frontiers in Cell and Developmental Biology, 2024 - frontiersin.org
43 天前 - … of pancreatic cancer that arises from the pancreatic ducts and accounts for more
than 90% of pancreatic cancer … (TME) comprising of desmoplastic stroma, cancer-associated …
than 90% of pancreatic cancer … (TME) comprising of desmoplastic stroma, cancer-associated …
Identifying the Morphological and Molecular Features of a Cell-Based Orthotopic Pancreatic Cancer Mouse Model during Growth over Time
FL Tansi, A Schrepper, M Schwarzer… - International Journal of …, 2024 - mdpi.com
51 天前 - … therapies such as chemotherapy, immunotherapy, and … of cell-based orthotopic
pancreatic cancer models in mice … collagen metabolism, tumor growth, and desmoplasia. It …
pancreatic cancer models in mice … collagen metabolism, tumor growth, and desmoplasia. It …
Current status of endoscopic ultrasound‐guided antitumor treatment for pancreatic cancer
K Matsumoto, H Kato, K Tsutsumi… - Digestive …, 2024 - Wiley Online Library
57 天前 - … Despite technological advancements, pancreatic cancer (PC) … desmoplasia and
hypovascular nature of the tumor, … cancer stages are managed with systemic chemotherapy. …
hypovascular nature of the tumor, … cancer stages are managed with systemic chemotherapy. …
[HTML][HTML] Correlation between Angiotensin Inhibitor Administration and Longer Survival in Patients Who Underwent Curative Resection for Pancreatic Cancer
HY Yang, MY Kang, CM Kang, WJ Lee… - Yonsei Medical …, 2024 - ncbi.nlm.nih.gov
62 天前 - … stroma and desmoplastic reactions associated with pancreatic cancer cause
hypovascularity and a hypoxic microenvironment that evoke acquired chemoresistance by …
hypovascularity and a hypoxic microenvironment that evoke acquired chemoresistance by …
… targeted nanoparticles release ERK-inhibitor in the hypoxic zone and sensitize free gemcitabine in mutant K-Ras-addicted pancreatic cancer cells and mouse model
73 天前 - … chemoresistance resulting from the addiction of mutant-K-RAS/AKT/ERK
signaling-mediated desmoplastic … characteristics of human pancreatic cancer with desmoplasia …
signaling-mediated desmoplastic … characteristics of human pancreatic cancer with desmoplasia …
相关搜索
- combination chemotherapy for pancreatic cancer
- chemotherapy for pancreatic cancer combat trial
- chemoresistance in pancreatic cancer co-culture model
- treatment with neoadjuvant chemotherapy pancreatic cancer
- longer survival in patients pancreatic cancer
- chemoresistance in pancreatic ductal adenocarcinoma
- targeted therapy in pancreatic cancer
- pancreatic cancer resistance
- maintenance therapy for unresectable pancreatic adenocarcinoma
- animal models of pancreatic cancer
- orthotopic pancreatic cancer mouse model
- prognosis of advanced pancreatic cancer
- resected pancreatic adenocarcinoma patients
- gemcitabine for pancreatic cancer therapy
- oncogene in pancreatic cancer
- mutant pancreatic cancer